ea0073aep894 | Late Breaking | ECE2021
Faki Sevgul
, Deniz Serdar
, Burçak Cavnar Helvacı
, Çağlar Keskin
, Burçak Polat
, Nilay Yüksel
, Şeyda Türkölmez
, Oya Topaloğlu
, Ersoy Reyhan
, BekirÇakir
BackgroundThe risk of cancer is relatively higher in GravesÂ’ patients presenting simultaneously with thyroid nodules. Radioiodine (RAI) therapy recommended in intermediate-high risk differentiated thyroid carcinoma may be associated with worsening of a pre-existing GravesÂ’ orbitopathy (GO) or developing a new onset. The impact of RAI therapy in patients with differentiated thyroid cancer on the course of a pre-exisiting GO has not been specific...